Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Excler

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
The Southeast Asian Journal of Tropical Medicine and Public Health|September 16, 2003
A joint clinical research center in Thailand: role in HIV vaccine developmentPatricia A Morgan, Suchada Chinaworapong, Jean-Louis Excler, et al.
Vaccine|February 17, 2026
The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges aheadNicole M Revie, Matthew Y Guo, Anne E Mullin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Review on the Recent Advances on Typhoid Vaccine Development and Challenges AheadKhalid Ali Syed, Tarun Saluja, Heeyoun Cho, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
AIDS Research and Human Retroviruses|November 4, 2010
AIDS vaccines and preexposure prophylaxis: is synergy possible?Jean-Louis Excler, Wasima Rida, Frances Priddy, et al.
AIDS Research and Human Retroviruses|June 8, 2014
Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblindingKessuda Khowsroy, Jittima Dhitavat, Yupa Sabmee, et al.
Vaccine|December 3, 2014
Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Stephen J Seligman, James S Robertson, et al.
Vaccine|October 20, 2020
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platformAriane Volkmann, Anna-Lise Williamson, Heinz Weidenthaler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2019
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product CharacteristicsJohan Vekemans, Fernando Gouvea-Reis, Jerome H Kim, et al.
Vaccine|December 1, 2018
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccinesSonali Kochhar, Jean-Louis Excler, Karin Bok, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
The Southeast Asian Journal of Tropical Medicine and Public Health|September 16, 2003
A joint clinical research center in Thailand: role in HIV vaccine developmentPatricia A Morgan, Suchada Chinaworapong, Jean-Louis Excler, et al.
Vaccine|February 17, 2026
The invasive non-typhoidal Salmonella vaccine landscape: Innovations and challenges aheadNicole M Revie, Matthew Y Guo, Anne E Mullin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Review on the Recent Advances on Typhoid Vaccine Development and Challenges AheadKhalid Ali Syed, Tarun Saluja, Heeyoun Cho, et al.
Emerging Infectious Diseases|July 21, 2016
Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015Jean-Louis Excler, Christopher J Delvecchio, Ryan E Wiley, et al.
AIDS Research and Human Retroviruses|November 4, 2010
AIDS vaccines and preexposure prophylaxis: is synergy possible?Jean-Louis Excler, Wasima Rida, Frances Priddy, et al.
AIDS Research and Human Retroviruses|June 8, 2014
Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblindingKessuda Khowsroy, Jittima Dhitavat, Yupa Sabmee, et al.
Vaccine|December 3, 2014
Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Stephen J Seligman, James S Robertson, et al.
Vaccine|October 20, 2020
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platformAriane Volkmann, Anna-Lise Williamson, Heinz Weidenthaler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2019
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product CharacteristicsJohan Vekemans, Fernando Gouvea-Reis, Jerome H Kim, et al.
Vaccine|December 1, 2018
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccinesSonali Kochhar, Jean-Louis Excler, Karin Bok, et al.
Pageof 12